FY2025 EPS Forecast for HealthStream Increased by Analyst

Key Points

• Analysts from Barrington Research increased their FY2025 earnings estimate for HealthStream to $0.67 per share, up from $0.65, while the current consensus estimate is $0.63.
• In its latest earnings report, HealthStream posted an earnings per share of $0.18, exceeding analysts' expectations, with a revenue of $74.40 million.
• The company announced a quarterly dividend of $0.031 per share and has approved a stock repurchase program worth $25 million, indicating confidence in the stock's value.

HealthStream, Inc. (NASDAQ:HSTM - Free Report) - Stock analysts at Barrington Research lifted their FY2025 earnings estimates for HealthStream in a research report issued on Tuesday, August 12th. Barrington Research analyst V. Colicchio now forecasts that the technology company will post earnings of $0.67 per share for the year, up from their prior estimate of $0.65. The consensus estimate for HealthStream's current full-year earnings is $0.63 per share.

HealthStream (NASDAQ:HSTM - Get Free Report) last released its earnings results on Monday, August 4th. The technology company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.16 by $0.02. HealthStream had a net margin of 6.89% and a return on equity of 5.70%. The firm had revenue of $74.40 million during the quarter, compared to analysts' expectations of $74.39 million. HealthStream has set its FY 2025 guidance at EPS.

Separately, Canaccord Genuity Group lowered their price target on HealthStream from $29.00 to $28.00 and set a "hold" rating on the stock in a research report on Thursday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, HealthStream presently has a consensus rating of "Moderate Buy" and a consensus target price of $31.00.

HealthStream Stock Down 0.1%

NASDAQ HSTM traded down $0.0340 on Thursday, reaching $26.6460. The company had a trading volume of 39,695 shares, compared to its average volume of 178,583. The stock has a market cap of $789.79 million, a price-to-earnings ratio of 39.75, a PEG ratio of 3.32 and a beta of 0.43. HealthStream has a 52 week low of $25.36 and a 52 week high of $34.24. The stock's 50 day moving average is $26.92 and its 200-day moving average is $29.77.

HealthStream Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Monday, August 18th will be given a dividend of $0.031 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Monday, August 18th. HealthStream's dividend payout ratio is currently 17.91%.

HealthStream declared that its board has authorized a share buyback plan on Thursday, May 8th that permits the company to buyback $25.00 million in outstanding shares. This buyback authorization permits the technology company to buy up to 3% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's leadership believes its stock is undervalued.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in HSTM. Copeland Capital Management LLC increased its position in HealthStream by 101.3% during the 1st quarter. Copeland Capital Management LLC now owns 763,690 shares of the technology company's stock valued at $24,576,000 after buying an additional 384,384 shares in the last quarter. Robeco Institutional Asset Management B.V. increased its stake in shares of HealthStream by 162.1% in the second quarter. Robeco Institutional Asset Management B.V. now owns 380,604 shares of the technology company's stock worth $10,531,000 after purchasing an additional 235,382 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in HealthStream by 302.0% in the 2nd quarter. JPMorgan Chase & Co. now owns 247,905 shares of the technology company's stock worth $6,860,000 after buying an additional 186,231 shares during the period. Qube Research & Technologies Ltd grew its position in shares of HealthStream by 77.3% during the second quarter. Qube Research & Technologies Ltd now owns 251,953 shares of the technology company's stock worth $6,972,000 after purchasing an additional 109,883 shares in the last quarter. Finally, Bridgeway Capital Management LLC purchased a new stake in HealthStream in the 1st quarter worth $3,228,000. Institutional investors own 69.58% of the company's stock.

HealthStream Company Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.